(AGNG) Global X Aging Population - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US37954Y7720
AGNG: Biotechnology, Medical Devices, Pharmaceuticals, Senior Living, Healthcare
The Global X Aging Population ETF (AGNG) is an investment vehicle that capitalizes on the demographic shift towards an aging global population, targeting companies that benefit from this trend. By investing over 80% of its assets in the securities of the Indxx Aging Population Thematic Index, the fund provides exposure to a diversified portfolio of exchange-listed companies in developed markets. These companies operate in various sectors, including biotechnology, medical devices, pharmaceuticals, senior living facilities, and specialized healthcare services, all of which are poised to benefit from the increasing demand for healthcare and age-related services.
The underlying index is designed to capture the growth potential of companies that are well-positioned to capitalize on the aging population trend. This includes businesses that develop innovative medical technologies, provide healthcare services tailored to the elderly, and operate facilities that cater to the needs of an aging demographic. As the global population continues to age, the demand for these services is expected to increase, potentially driving growth for the companies represented in the fund.
From a technical analysis perspective, the current price of AGNG is $31.30, with its short-term and long-term moving averages indicating a relatively stable trend. The SMA20 and SMA50 are $30.89 and $30.70, respectively, suggesting a potential support level around $30.70. The SMA200 is $31.47, indicating a potential resistance level. Given the ATR of 0.63, representing a 2.01% daily volatility, and considering the 52-week high and low of $33.01 and $28.23, respectively, it is reasonable to anticipate that the price will continue to fluctuate within this range. A breakout above $33.01 could signal further upside potential, while a drop below $28.23 might indicate a significant downturn.
Combining technical and fundamental insights, a forecast for AGNG can be developed. With an AUM of $56.38M USD, the fund has a solid foundation. Considering the demographic trend of an aging population, which is expected to continue driving demand for healthcare and related services, the companies within the funds portfolio are likely to experience growth. If the global economy continues to support the healthcare sector, and given the current technical indicators, it is plausible that AGNG could see its price move towards the upper end of its 52-week range, potentially testing the $33.01 level. However, any significant deviation from this trend would require a re-evaluation of the funds prospects.
Investors should closely monitor the funds performance in relation to the aging population trend and the overall healthcare sectors growth. A sustained increase in demand for age-related healthcare services could positively impact the fund, while any regulatory or economic changes affecting the healthcare industry could have negative implications. As such, a nuanced understanding of both the macroeconomic and sector-specific factors influencing AGNG is crucial for making informed investment decisions.
Additional Sources for AGNG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
AGNG ETF Overview
Market Cap in USD | 58m |
Category | Health |
TER | 0.50% |
IPO / Inception | 2016-05-09 |
AGNG ETF Ratings
Growth Rating | 31.6 |
Fundamental | - |
Dividend Rating | 48.1 |
Rel. Strength | -1.7 |
Analysts | - |
Fair Price Momentum | 29.90 USD |
Fair Price DCF | - |
AGNG Dividends
Dividend Yield 12m | 0.79% |
Yield on Cost 5y | 1.08% |
Annual Growth 5y | 20.11% |
Payout Consistency | 88.4% |
Payout Ratio | % |
AGNG Growth Ratios
Growth Correlation 3m | 28% |
Growth Correlation 12m | -6.5% |
Growth Correlation 5y | 57.6% |
CAGR 5y | 6.61% |
CAGR/Max DD 5y | 0.26 |
Sharpe Ratio 12m | 1.34 |
Alpha | -1.59 |
Beta | 0.549 |
Volatility | 15.66% |
Current Volume | 1.4k |
Average Volume 20d | 3.8k |
As of June 17, 2025, the stock is trading at USD 31.97 with a total of 1,380 shares traded.
Over the past week, the price has changed by +0.31%, over one month by +3.80%, over three months by +0.35% and over the past year by +7.45%.
Neither. Based on ValueRay´s Analyses, Global X Aging Population is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 31.55 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AGNG is around 29.90 USD . This means that AGNG is currently overvalued and has a potential downside of -6.47%.
Global X Aging Population has no consensus analysts rating.
According to our own proprietary Forecast Model, AGNG Global X Aging Population will be worth about 33.2 in June 2026. The stock is currently trading at 31.97. This means that the stock has a potential upside of +3.88%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 33.2 | 3.9% |